Navigating Telemedicine: Challenges Amid DEA’s Regulatory Delays

The dilemma revolves around the conflict between federal prescribing laws and state laws on continuity of care. Should the DEA allow current waivers to expire without a viable alternative, patients may find themselves without necessary in-person medical support.